Balance Sheet

Cash Flow Statement

Acquisitions Amortization Amortization Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Receivables Change in Receivables Deferred Taxes Dividends Paid - Common Dividends Paid - Common Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances

Daily Values

Growth Metrics

Qiagen (QGEN) Gains from Investment Securities (2021 - 2022)

Qiagen's Gains from Investment Securities history spans 7 years, with the latest figure at $1.0 million for Q4 2022.

On a quarterly basis, Gains from Investment Securities rose 118.52% to $1.0 million in Q4 2022 year-over-year; TTM through Dec 2022 was -$4.6 million, a 113.15% decrease, with the full-year FY2024 number at $15.7 million, down 80.95% from a year prior.
Gains from Investment Securities hit $1.0 million in Q4 2022 for Qiagen, up from -$5.7 million in the prior quarter.
Over the last five years, Gains from Investment Securities for QGEN hit a ceiling of $1.0 million in Q4 2022 and a floor of -$5.7 million in Q4 2021.